PORTLAND, Ore., July 15, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today the appointment of Charles N. Blitzer to its board of directors, increasing the membership to five.
